Cardiac Pacemaker Market Analysis, Business Overview and Forecast to 2025
Overview:
The
global cardiac pacemaker market is expecting a 7.9% CAGR during the forecast
period (2017-2023) to claim substantial market valuation by the end of 2023,
asserts Market Research Future (MRFR). This certain
growth can be attributed to several factors from its functional features to its
use in countering diverse health-related issues. Cardiac pacemaker’s use in maintaining regularity of the heart
rhythm by sending electrical pulses to the heart has gained traction in
treating atrial fibrillation (AFib) which is also the chief driver in taking
the cardiac pacemaker market ahead. Furthermore, the rising geriatric
population, with a predicted number of 2.1billion by 2050, is expanding the
cardiac pacemaker market horizon.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/2025
However,
cardiac pacemakers incur high cost which
can be a hurdle for the cardiac pacemaker market during the forecast period. At
the same time, its implantation procedure requires surgery and risks of
malfunctioning can add further woe.
Industry Trend:
Researchers
at the University of Ottawa Heart
Institute completed the first successful
implant in 2018 of a Micra Leadless Transcatheter Pacing System, which is the
latest model of its category and the smallest leadless pacemaker in the world.
The process allows the machine to be implanted directly within the heart,unlike other pacemakers.
Practitioners
at Children's Hospital Los Angeles and the University of Southern California
have developed a micropacemaker system
requiring implantation in the pericardial sac which could be a breakthrough in
cardiac surgery options for children and adults.
Segmentation Analysis:
The
global Cardiac Pacemaker Market can
be segmentedby type, technology,
application, and end-users.
Based
on type, the cardiac pacemaker market
includes implantable, external cardiac pacemaker, and others.
Technology-wise,
the cardiac pacemaker market comprises biventricular, single-chambered,
dual-chambered, and others.
Application-based
segmentation of the cardiac pacemaker market consists
arrhythmias, congestive heart failure, and others. Arrhythmias segment can be
sub-segmented into tachycardia, bradycardia, and others.
Based
on the end-users, the market cardiac pacemaker includes hospitals, cardiac care
centers, medical institutes, and others.
Regional Analysis:
Geographical
analysis of cardiac pacemaker market includes regions namely the Americas,
Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The
Americas has the lead in the global market,and
they can attribute this to a superior infrastructure, and better healthcare
policies. Furthermore, a considerable
patient pool is also playing in favor of
cardiac pacemaker market. Changing lifestyle and high healthcare expenditure
are proving essential for the regional market growth.
Europe
is following the lead and is experiencing considerable growth owing to regular
investment in research and development. Governments taking a keen interest in the sector has a positive
impact on the market.
Access Full Report Details @ https://www.marketresearchfuture.com/reports/cardiac-pacemaker-market-2025
The
APAC is the fastest growing region with India and China continually improving their industrial landscape. In addition, many countries of this region are
emerging as a medical tourism hub and
helping the regional cardiac pacemaker market witness unprecedented growth.The
MEA region’s growth will be slow due to lack of infrastructure and poor
economic regions.
Market Insight:
The
cardiac pacemaker market has several global players who engage in strategic
developments to ace the field. These developments include merger, acquisition, collaboration, new product
launch,and other methods. For instance,
Medtronic is acquiring shares in Chinese company LifeTech Scientific to gain
hold of the Chinese market. Stryker, on the other hand, is trying to buyBoston Scientific Corporation in a bid to
expand their portfolio.
Prominent
names in the global cardiac pacemaker market are Medtronic (U.S.), Abbott.
(U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK (Germany), LEPU MEDICAL
(U.K), SORIN Group (Europe), MEDICO S.p.A. (Europe), OSCOR Inc. (U.S.), and
others.
Comments
Post a Comment